Although the vast majority of parotid AcCCs do express NR4A3 by immunohistochemistry, the lack of NR4A3 mRNA expression in our case does not directly argue against the diagnosis, as little is known regarding the NR4A3 gene status in non-parotid manifestations of this tumor type [50]. This evidence concerns the gene NR4A3 and neoplasm.